[183 Pages Report] The Biopsy Devices Market size was estimated at USD 9.47 billion in 2023 and expected to reach USD 10.46 billion in 2024, at a CAGR 10.82% to reach USD 19.46 billion by 2030.
The biopsy devices are used explicitly in diagnostic procedures that involve the extraction of sample cells and tissues for examination aimed at identifying the existence and extent of a disease. These devices range from needle biopsy devices, biopsy guidance systems to biopsy forceps. Biopsy devices have a crucial role in several medical applications pertaining to disease detection and monitoring, including breast biopsy, gastrointestinal biopsy, prostate biopsy, liver biopsy, and lung biopsy. An increasing prevalence of cancer worldwide and a growing preference for minimally invasive surgeries are pivotal factors driving the market growth. In contrast, high equipment costs, risks associated with biopsy procedures, and the stringent regulatory hurdles by health authorities hinder the market growth. However, several vendors are focusing on R&D to overcome these issues. Furthermore, advancements in the manufacturing process of biopsy devices, extending the usage of biopsy devices in research and tissue banking, improved healthcare infrastructures, and investments in emerging economies contribute to market expansion.
Biopsy forceps are sophisticated, hand-held devices used during minimally invasive procedures, designed with a two-leaf structure; they are adept at extracting tissue samples from targeted areas with sheer precision and minimal patient discomfort. Localization wires act as a guide in identifying the correct area for biopsy, particularly in breast biopsy procedures. They are used preoperatively to seperate non-palpable lesions detected during mammography or ultrasound, ensuring precision and aiding radiologists in obtaining tissue samples. Needle-based biopsy instruments are preferred for deep-seated lesions; common types include fine-needle aspiration and core-needle biopsies. These devices reduce procedural complications and are known for their efficiency in obtaining high-quality samples, helping in precise diagnoses. Needle-based biopsy instruments include aspiration needles, core biopsy devices, and vacuum-assisted biopsy devices. Aspiration needles play a crucial role in fine-needle aspiration biopsy procedures, often used to investigate lumps or masses. Core biopsy devices remove a small tissue section for pathological examination, usually used in breast, liver, or bone biopsies. Vacuum-assisted biopsy devices are remarkably efficient tools for minimally invasive biopsy procedures. Employing a vacuum mechanism, these devices allow for a continuous tissue sample to be acquired without reinserting the needle. Procedure trays are a compact, systematic solution encompassing all necessary biopsy tools for a specific procedure. They optimize the workflow, promote efficient resource use, and enhance the sterility of the procedure.
Image-guided biopsy is a noteworthy innovation in the realm of biopsy devices, harnessing the precision of modern imaging technologies. This advanced technique enables doctors to extract samples from difficult-to-access areas, leading to a more accurate and less invasive procedure. Image-guided biopsy includes MRI-guided biopsy, stereotactic-guided biopsies, and ultrasound-guided biopsy. MRI-guided biopsy has become a preferred technique for diagnosing abnormalities located in difficult-to-reach areas or those of more intricate structures such as the brain and the breast. Stereotactic-guided biopsies are more applicable for relatively superficial abnormalities, including those in the breast and lesions close to the skin. This technique is a boon for patients to avoid the discomfort of invasive procedures while still ensuring a highly accurate diagnosis. Ultrasound-guided biopsy primarily leverages its advantage in real-time image provision, making it the go-to option for neck, chest, and abdomen biopsies. Furthermore, it is a cost-effective and faster way of performing biopsies and is preferred in situations where cost and time are primary considerations. In comparison, MRI-guided biopsy stands at the forefront of advanced cases, stereotactic biopsy rings are necessary for superficial cases, and ultrasound-guided offerings are proven beneficial in real-time requirements and cost-effective scenarios. Non-image guided biopsy includes techniques where palpation or anatomical landmarks are used to determine the biopsy site without the assistance of live-image guidance. The choice between image-guided and non-image-guided biopsies largely depends on the location and nature of the lesion, the patient’s health status, and the resources available. Image-guided biopsy methods are leading in the context of precision and safety, particularly for non-palpable and deep-seated lesions. However, non-image-guided procedures remain a fast and cost-effective option for superficial masses.
The upsurge in breast cancer cases worldwide has subsequently triggered the need for breast biopsy devices. Devices such as vacuum-assisted biopsy (VAB) systems attain favor for their minimally invasive nature, confident diagnosis, and high-speed, painless process. Flexible sigmoidoscopes are preferred for colorectal biopsy due to their ability to detect abnormalities in the rectum and sigmoid colon. The rising incidence of lung conditions, including cancer, triggers the need for lung biopsy devices, where transthoracic needle biopsy (TTNB) devices are commonly used. Prostate biopsy procedures largely use transrectal ultrasound (TRUS) guided prostate biopsy devices, as per need-based preference. Biopsy devices for breast and prostate biopsies are undergoing significant technological advancement owing to rising cancer rates. Simultaneously, devices for lung and colorectal biopsies address a range of illnesses, cancer included. Biopsy devices remain paramount in medical diagnosis, reflecting continuous progress and ensuring patient health.
Academic and research institutes pursue innovative solutions for improving the accuracy and efficiency of biopsy procedures, with a particular emphasis on non-invasive techniques. These institutions seek sophisticated and advanced biopsy devices that allow them to explore new frontiers of medical research. Diagnostic and imaging centers focus primarily on timely and accurate diagnosis. They require biopsy devices that facilitate rapid sample collection with minimal patient discomfort. Biopsy devices that allow for shorter recovery times, fewer complications, and lower costs are ideally preferred by primary healthcare providers and hospitals as they mainly focus on patient safety, comfort, and cost-effectiveness. The shared objective across these user groups is to enhance biopsy procedure accuracy and efficiency. The varied sector needs to drive market evolution, promising more subtle innovations and improved global health outcomes.
The Americas region has witnessed a rising trend in the utilization of biopsy devices due to the increase in various cancer cases. According to the American Cancer Society, in 2023, there are estimated to be 1,958,310 new cancer cases. This directly contributes to the need for biopsy devices. State-of-the-art technology and medical advancements, alongside favorable reimbursement policies in this region, contribute to the market growth. Also, growing awareness about early detection of cancer, reinforced by strong healthcare marketing, paves the path for increased use of biopsy devices in the region. Furthermore, the EMEA region, characterized by rapidly aging populations and a high incidence of cancer, has a strong need for biopsy devices. The market inflow is also credited to the adoption of technologically advanced healthcare equipment and infrastructure. National healthcare systems in this region promote timely and accurate cancer diagnosis, enabling increased biopsy device utilization. The awareness campaigns by the World Health Organization (WHO) and the European Institute of Oncology stimulate the need for biopsy devices in the region. Moreover, the APAC region is experiencing a rapid increase in lifestyle-related diseases, including cancers. The aging population, environmental pollution, and unhealthy lifestyle habits are fueling the incidences of cancer, thereby increasing the need for biopsy devices. In addition, improving healthcare systems, increasing healthcare spending, and raising awareness about early cancer detection are other factors fostering the adoption of biopsy devices.
The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
LUMINELLE Announces China National Intellectual Property Administration’s Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
LUMINELLE (UVision360, Inc.) has been granted a Chinese patent titled "Biopsy Device and Method" for its Bx System, securing international intellectual property rights. This groundbreaking system reduces the need for anesthesia, allowing for accurate sampling in the office setting. [Published On: 2023-10-05]
Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
Limaca Medical Ltd.'s Precision GI Endoscopic Ultrasound (EUS) Biopsy Device has received 510(k) clearance from the FDA after being designated as a Breakthrough Device. This device is designed to enhance the accuracy and efficiency of biopsies, enabling a more definitive diagnosis of pancreatic and other gastrointestinal (GI) cancers. [Published On: 2023-09-11]
Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
Stryker Corporation launched the Q Guidance System with Cranial Guidance Software. This innovative system is designed to assist surgeons in accurately positioning instruments and identifying patient anatomy during cranial surgery. It is particularly beneficial for craniotomies, skull base and transsphenoidal procedures, shunt placements, and biopsies. [Published On: 2023-07-11]
The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Axlab Limited, B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CONMED Corporation, Cook Group Incorporated, Danaher Corporation, F. Hoffmann-La Roche Ltd., Ferrosan Medical Devices A/S, Fujifilm Holdings Corporation, Guardant Health, Inc., Hologic, Inc., Innovia Medical, INRAD, Inc., Integra LifeSciences Holdings Corporation, IZI Medical Products, LLC by Halma PLC, JEB Technologies Limited, Limaca-Medical, MediTech Devices Pvt Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical, Olympus Corporation, PAJUNK GmbH Medizintechnologie, Remington Medical, Spectra Medical Devices, LLC, Stryker Corporation, Suretech Medical Inc., Trajan Scientific and Medical Pty Ltd., TransMed7, LLC, TSK Laboratory, UVision360, Volkmann MedizinTechnik GmbH, weLLgo Medical Products GmbH, and Zamar Care.
This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Biopsy Forceps
- Localization Wires
- Needle-Based Biopsy Instruments
- Aspiration Needles
- Core Biopsy Devices
- Vacuum-Assisted Biopsy Devices
- Procedure Trays
- Technique
- Image Guided Biopsy
- MRI-Guided Biopsy
- Stereotactic-Guided Biopsy
- Ultrasound-Guided Biopsy
- Non-Image Guided Biopsy
- Image Guided Biopsy
- Application
- Bone Marrow Biopsy
- Breast Biopsy
- Kidney Biopsy
- Lung Biopsy
- Prostate Biopsy
- End User
- Academic & Research Institutes
- Diagnostic & Imaging Centers
- Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Biopsy Devices Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Devices Market?
- What are the technology trends and regulatory frameworks in the Biopsy Devices Market?
- What is the market share of the leading vendors in the Biopsy Devices Market?
- Which modes and strategic moves are suitable for entering the Biopsy Devices Market?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Biopsy Devices Market, by Product
- Biopsy Devices Market, by Technique
- Biopsy Devices Market, by Application
- Biopsy Devices Market, by End User
- Americas Biopsy Devices Market
- Asia-Pacific Biopsy Devices Market
- Europe, Middle East & Africa Biopsy Devices Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 24]
- List of Tables [Total: 560]
- List of Companies Mentioned [Total: 38]
Rise of Minimally-Invasive Surgery Techniques:
In recent years, there has been a remarkable emergence in minimally invasive surgery techniques, which have become the preference of both patients and healthcare providers. Modern biopsy devices contribute considerably to minimally invasive procedures, which allow patients to undergo treatment with lower risk factors and result in quicker recovery times. This shift in approach has been adopted due to its numerous benefits over traditional or open surgeries, including smaller incisions, less postoperative pain, and quicker recovery times.
Biopsy Devices: Innovative, Specific And Accurate
Biopsy devices have come a long way since their evolution. In the early days, the procedure was very invasive and painful and offered inadequate diagnosis results. Biopsy devices have revolutionized the way biopsy procedures are done today, allowing for less tissue removal, greater accuracy, and specific diagnosis results. Generally, there are three types of biopsy devices: core needle biopsy, fine needle aspiration, and vacuum-assisted biopsy. These devices have been instrumental in several diagnostic procedures, including breast, liver, and lung cancers, among many others.
Growing Adoption of Biopsy Devices
The healthcare industry has seen a surge in the adoption of biopsy devices due to health practitioners’ progressively growing demand for more specific diagnostic procedures and minimally invasive surgical techniques. The minimally invasive techniques ensure less discomfort, less injury, speedier recoveries, fewer complications, and lower morbidity rates. Biopsy devices offer a targeted approach that increases the sensitivity and accuracy of the diagnostic process.
The Role of Biopsy Devices in Medical Advancements
Advancement in biopsy devices has created a stimulus in healthcare development and has impacted several medical fields. The role of biopsy devices is particularly crucial in oncology disease diagnosis and immunological research. The emergence of these innovative biopsy devices has, therefore, created an avenue for drug discovery and effective cancer therapy. These devices have offered a better understanding of immunology and cell biology, offering an increased insight into discovering effective and accurate diagnostic methods that hold the potential to revolutionize the healthcare industry.
Biopsy Devices have undoubtedly improved diagnostics in the medical field, allowing for accurate, innovative, and effective sample collection and diagnoses. The growing adoption of biopsy devices in minimally invasive surgical techniques is a testament to the medical advantages of these devices in patient care and overall recovery. The medical advancements, growing market opportunities, and consistent adoption will continue to boost the biopsy devices market while pushing the healthcare industry's frontiers. With better biopsy diagnosis results come better patient outcomes, boosted confidence, minimized complications, reduced treatment costs, and, most notably, higher chances of survival for patients.
- How big is the Biopsy Devices Market?
- What is the Biopsy Devices Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?